Cargando…

The myeloid response to pancreatic carcinogenesis is regulated by the receptor for advanced glycation end-products

We identified a critical role for receptor for advanced glycation end products (RAGE) in the intratumoral accumulation of myeloid-derived suppressor cells (MDSCs) during pancreatic carcinogenesis. The absence of RAGE markedly delayed neoplasia and limited MDSC accumulation in mice expressing an onco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vernon, Philip J., Zeh III, Herbert J., Lotze, Michael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667906/ https://www.ncbi.nlm.nih.gov/pubmed/23762800 http://dx.doi.org/10.4161/onci.24184

Ejemplares similares

The Receptor for Advanced Glycation End-products (RAGE) Sustains Autophagy and Limits Apoptosis, Promoting Pancreatic Tumor Cell Survival
por: Kang, Rui, et al.
Publicado: (2009)

The Receptor for Advanced Glycation End Products (RAGE) Enhances Autophagy and Neutrophil Extracellular Traps in Pancreatic Cancer
por: Boone, Brian A., et al.
Publicado: (2015)

Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis
por: Kauppila, Joonas H., et al.
Publicado: (2013)

How two sites of inflammation promote carcinogenesis: The role of macrophages in inflammation associated carcinogenesis
por: Sebens, Susanne, et al.
Publicado: (2012)

Emerging role of CD300 receptors in regulating myeloid cell efferocytosis
por: Voss, Oliver H, et al.
Publicado: (2015)

Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications
por: Schröter, David, et al.
Publicado: (2019)

Chemotherapy engages multiple pathways leading to IL-1β production by myeloid leukocytes
por: Antonopoulos, Christina, et al.
Publicado: (2014)

The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppression
por: Basso, Daniela, et al.
Publicado: (2013)

Clearance Kinetics and Matrix Binding Partners of the Receptor for Advanced Glycation End Products
por: Milutinovic, Pavle S., et al.
Publicado: (2014)

Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma
por: Beatty, Gregory L
Publicado: (2014)

Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis
por: Bastid, Jérémy, et al.
Publicado: (2014)

Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
por: Morello, Silvana, et al.
Publicado: (2014)

Acute myeloid leukemia therapeutics: CARs in the driver’s seat
por: Mardiros, Armen, et al.
Publicado: (2013)

Monocytic myeloid-derived suppressor cells in advanced melanoma patients: Indirect impact on prognosis through inhibition of tumor-specific T-cell responses?
por: Martens, Alexander, et al.
Publicado: (2014)

Targeting cathepsin G in myeloid leukemia
por: Alatrash, Gheath
Publicado: (2013)

CCPG1, an unconventional cargo receptor for ER-phagy, maintains pancreatic acinar cell health
por: Smith, Matthew D., et al.
Publicado: (2018)

Interferon α may be back on track to treat acute myeloid leukemia
por: Smits, Evelien L.J.M., et al.
Publicado: (2013)

Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis
por: Lim, Su Yin, et al.
Publicado: (2013)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

SIN3B, the SASP, and pancreatic cancer
por: Cantor, David J, et al.
Publicado: (2014)

A co-stimulatory trap set by myeloid leukemia cells
por: Esendagli, Gunes
Publicado: (2013)

Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
por: Horibata, Sachi
Publicado: (2019)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

Telomeres and sirtuins: at the end we meet again
por: Amano, Hisayuki, et al.
Publicado: (2019)

Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer
por: Thompson, Timothy C., et al.
Publicado: (2017)

Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis
por: Nemenoff, Raphael
Publicado: (2012)

Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
por: Arina, Ainhoa
Publicado: (2014)

Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease
por: Sawant, Anandi, et al.
Publicado: (2013)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology
por: Husain, Zaheed, et al.
Publicado: (2013)

Mast cells in pancreatic ductal adenocarcinoma
por: Chang, David Z.
Publicado: (2012)

The pancreatic cancer microenvironment: an immunologic battleground
por: Pillarisetty, Venu G
Publicado: (2014)

The dark side of ferroptosis in pancreatic cancer
por: Liu, Jiao, et al.
Publicado: (2021)

An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1)
por: Chiang, Shu-Fen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_577mcp8176ufuf011fdi19370i